<p>/PRNewswire/ -- Solventum（纽约证券交易所代码：SOLV），前身为 3M 医疗保健，今天宣布推出 Attest™ eBowie-Dick 测试系统（eBowie-Dick 系统），这是一种用于灭菌测试的电子测试卡和自动读取器，消除了对结果的视觉解读和手动记录的需求。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Solventum 推出 Attest™ eBowie-Dick 测试系统，彻底改变灭菌保障</p>
<p>在不到五秒钟的时间内，eBowie-Dick 系统简单的 “通过” 或 “失败” 数字显示提供明确的测试结果，并创建一个可以集成到医院仪器追踪系统中的自动记录，消除了扫描模拟测试结果的需要。</p>
<p>传统的蒸汽动态空气去除灭菌器测试使用变色墨水指示器来评估空气去除的有效性并检测灭菌器中的泄漏。墨水指示器被夹在纸包装的层之间。当从包装中取出墨水指示器以评估测试结果时，纸张会被丢弃。</p>
<p>与传统的 Bowie-Dick 测试包相比，eBowie-Dick 测试系统可以将进入医院废物流的 Bowie-Dick 测试纸张浪费减少 94%*。</p>
<p>“我们的新 eBowie-Dick 系统通过减少处理时间、消除传统方法固有的变异性，并且设备的软件功能提供了当前测试无法实现的高级分析，彻底改变了灭菌测试，” Solventum 医疗外科集团执行副总裁 Chris Barry 表示。“通过数字化，Solventum 正在为灭菌保障专业人士节省时间并减少废物，以帮助创造一个更可持续的未来。”</p>
<p>eBowie-Dick 系统现已在美国通过授权分销合作伙伴提供，并将在 2025 年全球推出 **。</p>
<p><strong>关于 Solventum</strong> 在 Solventum，我们致力于提供更好、更智能、更安全的医疗保健，以改善生活。作为一家拥有悠久历史的新公司，我们为客户最棘手的挑战创造突破性解决方案，在健康、材料和数据科学的交汇处开创改变游戏规则的创新，改善患者的生活，同时赋能医疗专业人士发挥最佳表现。请访问 Solventum.com 了解更多信息。</p>
<p><strong>前瞻性声明</strong> 本新闻稿包含关于 Solventum 财务业绩、估计和商业前景的前瞻性信息，这些信息涉及重大风险和不确定性。特别是，关于 Solventum 未来表现的声明，包括 2024 年的指导，是前瞻性声明。您可以通过使用诸如 “预期”、“相信”、“可能”、“估计”、“期望”、“预测”、“目标”、“指导”、“意图”、“可能”、“展望”、“计划”、“项目”、“寻求”、“看到”、“应该”、“目标”、“将”、“会” 等词语以及与任何未来运营或财务表现或商业计划或前景讨论相关的其他类似词语和术语来识别这些声明。可能导致实际结果显著不同的因素包括以下几点：（1）全球经济、政治、监管、国际、贸易和地缘政治条件、自然灾害、战争、公共卫生危机以及其他超出 Solventum 控制的事件的影响和变化；（2）运营执行风险；（3）对我们声誉或品牌的损害；（4）收购、战略联盟、剥离和其他战略事件的风险；（5）Solventum 与各市场第三方合作伙伴的商业交易；（6）Solventum 进入资本和信贷市场的能力以及 Solventum 信用评级的变化；（7）利率和货币风险的暴露；（8）Solventum 所处的高度竞争环境以及医疗行业的整合；（9）客户研究预算或政府资金的减少；（10）Solventum 新产品和服务的推出时机及市场接受度；（11）与某些关键医疗专业人士的持续工作关系；（12）政府或私人支付者的报销实践或其他成本控制措施的变化；（13）Solventum 获取第三方供应的组件或原材料的能力以及其他制造和相关供应链的困难、中断和破坏性因素；（14）与反垄断、外国腐败行为法（FCPA）及其他反贿赂法律、环境法律、反回扣和虚假索赔法律、隐私法律、税法以及 Solventum 运营所在国家的其他法律法规相关的法律和监管程序及法律合规风险（包括第三方风险）；（15）与一大类全氟烷基和多氟烷基物质（统称为 “PFAS”）相关的潜在责任；（16）与 Solventum 所处的高度监管环境相关的风险；（17）与产品责任索赔相关的风险；（18）气候变化及应对气候变化的措施；（19）信息技术基础设施的安全漏洞和其他干扰；（20）Solventum 未能获得、维护、保护或有效执行其知识产权（“IP”）权利；（21）养老金和退休后义务负债；（22）3M 公司（“3M”）未能履行与与 3M 分离相关的各种分离协议下的任何义务（“分拆”）；（23）未能实现分拆的预期利益，和/或分拆未能在预期的时间框架、预期的条款或根本未能完成；（24）美国国税局或其他税务机关认定分配或某些相关交易应视为应税交易；（25）与分拆相关的预期融资交易及与额外债务相关的风险；（26）在独立运营基础上运营的增量成本（包括协同效应的损失）、重组交易的成本及与分拆相关的其他成本超过 Solventum 的估计的风险；以及（27）分拆对其业务的影响以及分拆可能比预期更困难、耗时或成本更高的风险，包括对其资源、系统、程序和控制的影响、管理层注意力的分散以及对客户、供应商、员工和其他商业交易对手关系的影响。</p>
<p>对这些假设或因素的变化可能会产生显著不同的结果。有关这些因素的进一步描述，请参阅 Solventum 在美国证券交易委员会备案的定期报告中的 “关于前瞻性声明的警示说明” 和 “风险因素”。Solventum 不承担因新信息或未来事件或发展而更新本文中讨论的任何前瞻性声明的义务。</p>
<p>* 与 3M Bowie-Dick 纸质测试包产生的废物相比。废物质量基于 eBowie-Dick 10135B 产品和包装箱重量，按每个测试计算百分比。</p>
<p>** 某些国家可能因额外的地方监管要求而延迟。</p>
<p>来源：Solventum</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzEyJk5ld3NJdGVtSWQ9Q0czODk2OSZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMTIwODEyUFJfTkVXU19VU1BSX19fX19DRzM4OTY5?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzEyJk5ld3NJdGVtSWQ9Q0czODk2OSZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMTIwODEyUFJfTkVXU19VU1BSX19fX19DRzM4OTY5"/></p>

SOLV

<p>Solventum（纽约证券交易所代码：SOLV），前身为 3M 医疗保健，推出了 Attest™ eBowie-Dick 测试系统，这是一种电子灭菌测试解决方案，能够提供快速的数字结果，并减少 94% 的纸张浪费。该系统自动化文档处理，并与医院追踪系统集成，提高了灭菌保障的效率和可持续性。该产品在美国上市，并计划于 2025 年前在全球推广。Solventum 旨在通过创新解决方案改善医疗保健，同时应对其业务运营中的潜在风险和不确定性</p>

<p>, /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Solventum（纽约证券交易所代码：SOLV），前身为 3M 医疗保健，今天宣布推出 Attest™ eBowie-Dick 测试系统（eBowie-Dick 系统），这是一种用于灭菌测试的电子测试卡和自动读取器，消除了对结果的视觉解读和手动记录的需求。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance</p>
<div class="lb-trans"><p>Solventum 推出 Attest™ eBowie-Dick 测试系统，彻底改变灭菌保障</p>
</div><p>In less than five seconds, the eBowie-Dick System's simple &#34;pass&#34; or &#34;fail&#34; digital display provides definitive test results and creates an automated record that can be integrated into a hospital's instrument tracking system, eliminating the need to scan analog test results.</p>
<div class="lb-trans"><p>在不到五秒钟的时间内，eBowie-Dick 系统简单的 “通过” 或 “失败” 数字显示提供明确的测试结果，并创建一个可以集成到医院仪器追踪系统中的自动记录，消除了扫描模拟测试结果的需要。</p>
</div><p>Traditional tests for steam dynamic-air removal sterilizers use a color-changing ink indicator to evaluate the efficacy of air removal and detect leaks in the sterilizer. The ink indicator is tucked between layers of a paper packet. The paper is discarded when the ink indicator is removed from the packet to assess the test results.</p>
<div class="lb-trans"><p>传统的蒸汽动态空气去除灭菌器测试使用变色墨水指示器来评估空气去除的有效性并检测灭菌器中的泄漏。墨水指示器被夹在纸包装的层之间。当从包装中取出墨水指示器以评估测试结果时，纸张会被丢弃。</p>
</div><p>The eBowie-Dick Test System can reduce the paper waste from Bowie-Dick tests entering a hospital's waste stream by 94%* compared to paper waste generated by traditional Bowie-Dick Test Packs.</p>
<div class="lb-trans"><p>与传统的 Bowie-Dick 测试包相比，eBowie-Dick 测试系统可以将进入医院废物流的 Bowie-Dick 测试纸张浪费减少 94%*。</p>
</div><p>&#34;Our new eBowie-Dick System revolutionizes sterilization testing by reducing processing times, eliminating the variability inherent to traditional methods, and the device's software capabilities provide advanced analytics not possible with today's tests,&#34; said Chris Barry, executive vice president, group president, Medical Surgical, Solventum. &#34;Through digitization, Solventum is saving sterilization assurance professionals time and reducing waste to help create a more sustainable future.&#34;</p>
<div class="lb-trans"><p>“我们的新 eBowie-Dick 系统通过减少处理时间、消除传统方法固有的变异性，并且设备的软件功能提供了当前测试无法实现的高级分析，彻底改变了灭菌测试，” Solventum 医疗外科集团执行副总裁 Chris Barry 表示。“通过数字化，Solventum 正在为灭菌保障专业人士节省时间并减少废物，以帮助创造一个更可持续的未来。”</p>
</div><p>The eBowie-Dick System is now available in the United States from authorized distribution partners and will roll out globally throughout 2025**.</p>
<div class="lb-trans"><p>eBowie-Dick 系统现已在美国通过授权分销合作伙伴提供，并将在 2025 年全球推出 **。</p>
</div><p><strong>About Solventum</strong> At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.</p>
<div class="lb-trans"><p><strong>关于 Solventum</strong> 在 Solventum，我们致力于提供更好、更智能、更安全的医疗保健，以改善生活。作为一家拥有悠久历史的新公司，我们为客户最棘手的挑战创造突破性解决方案，在健康、材料和数据科学的交汇处开创改变游戏规则的创新，改善患者的生活，同时赋能医疗专业人士发挥最佳表现。请访问 Solventum.com 了解更多信息。</p>
</div><p><strong>Forward-Looking Statements</strong> This news release contains forward-looking information about Solventum's financial results, estimates, and business prospects that involve substantial risks and uncertainties. In particular, statements regarding the future performance of Solventum, including guidance for 2024, are forward-looking statements. You can identify these statements by the use of words such as &#34;anticipates,&#34; &#34;believes,&#34; &#34;could,&#34; &#34;estimates,&#34; &#34;expects,&#34; &#34;forecasts,&#34; &#34;goal,&#34; &#34;guidance,&#34; &#34;intends,&#34; &#34;may,&#34; &#34;outlook,&#34; &#34;plans,&#34; &#34;projects,&#34; &#34;seeks,&#34; &#34;sees,&#34; &#34;should,&#34; &#34;targets,&#34; &#34;will,&#34; &#34;would,&#34; and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) the effects of, and changes in, worldwide economic, political, regulatory, international, trade and geopolitical conditions, natural disasters, war, public health crises, and other events beyond Solventum's control; (2) operational execution risks; (3) damage to our reputation or our brands; (4) risks from acquisitions, strategic alliances, divestitures and other strategic events; (5) Solventum's business dealings involving third-party partners in various markets; (6) Solventum's ability to access the capital and credit markets and changes in Solventum's credit ratings; (7) exposure to interest rate and currency risks; (8) the highly competitive environment in which Solventum operates and consolidation in the healthcare industry; (9) reduction in customers' research budgets or government funding; (10) the timing and market acceptance of Solventum's new product and service offerings; (11) ongoing working relationships with certain key healthcare professionals; (12) changes in reimbursement practices of governments or private payers or other cost containment measures; (13) Solventum's ability to obtain components or raw materials supplied by third parties and other manufacturing and related supply chain difficulties, interruptions, and disruptive factors; (14) legal and regulatory proceedings and legal compliance risks (including third-party risks) with regards to antitrust, Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws, environmental laws, anti-kickback and false claims laws, privacy laws, tax laws, and other laws and regulations in the United States and other countries in which Solventum operates; (15) potential liabilities related to a broad group of perfluoroalkyl and polyfluoroalkyl substances, collectively known as &#34;PFAS&#34;; (16) risks related to the highly regulated environment in which Solventum operates; (17) risks associated with product liability claims; (18) climate change and measures to address climate change; (19) security breaches and other disruptions to information technology infrastructure; (20) Solventum's failure to obtain, maintain, protect, or effectively enforce its intellectual property (&#34;IP&#34;) rights; (21) pension and postretirement obligation liabilities; (22) any failure by the 3M Company (&#34;3M&#34;) to perform any of its obligations under the various separation agreements in connection with the separation from 3M (the &#34;Spin-Off&#34;); (23) any failure to realize the expected benefits of the Spin-Off, and/or that the Spin-Off will not be completed within the expected time frame, on the expected terms or at all; (24) a determination by the IRS or other tax authorities that the distribution or certain related transactions should be treated as taxable transactions; (25) expected financing transactions undertaken in connection with the separation and risks associated with additional indebtedness; (26) the risk that incremental costs of operating on a standalone basis (including the loss of synergies), costs of restructuring transactions and other costs incurred in connection with the separation will exceed Solventum's estimates; and (27) the impact of the Spin-Off on its businesses and the risk that the Spin-Off may be more difficult, time-consuming or costly than expected, including the impact on its resources, systems, procedures and controls, diversion of management's attention and the impact on relationships with customers, suppliers, employees and other business counterparties.</p>
<div class="lb-trans"><p><strong>前瞻性声明</strong> 本新闻稿包含关于 Solventum 财务业绩、估计和商业前景的前瞻性信息，这些信息涉及重大风险和不确定性。特别是，关于 Solventum 未来表现的声明，包括 2024 年的指导，是前瞻性声明。您可以通过使用诸如 “预期”、“相信”、“可能”、“估计”、“期望”、“预测”、“目标”、“指导”、“意图”、“可能”、“展望”、“计划”、“项目”、“寻求”、“看到”、“应该”、“目标”、“将”、“会” 等词语以及与任何未来运营或财务表现或商业计划或前景讨论相关的其他类似词语和术语来识别这些声明。可能导致实际结果显著不同的因素包括以下几点：（1）全球经济、政治、监管、国际、贸易和地缘政治条件、自然灾害、战争、公共卫生危机以及其他超出 Solventum 控制的事件的影响和变化；（2）运营执行风险；（3）对我们声誉或品牌的损害；（4）收购、战略联盟、剥离和其他战略事件的风险；（5）Solventum 与各市场第三方合作伙伴的商业交易；（6）Solventum 进入资本和信贷市场的能力以及 Solventum 信用评级的变化；（7）利率和货币风险的暴露；（8）Solventum 所处的高度竞争环境以及医疗行业的整合；（9）客户研究预算或政府资金的减少；（10）Solventum 新产品和服务的推出时机及市场接受度；（11）与某些关键医疗专业人士的持续工作关系；（12）政府或私人支付者的报销实践或其他成本控制措施的变化；（13）Solventum 获取第三方供应的组件或原材料的能力以及其他制造和相关供应链的困难、中断和破坏性因素；（14）与反垄断、外国腐败行为法（FCPA）及其他反贿赂法律、环境法律、反回扣和虚假索赔法律、隐私法律、税法以及 Solventum 运营所在国家的其他法律法规相关的法律和监管程序及法律合规风险（包括第三方风险）；（15）与一大类全氟烷基和多氟烷基物质（统称为 “PFAS”）相关的潜在责任；（16）与 Solventum 所处的高度监管环境相关的风险；（17）与产品责任索赔相关的风险；（18）气候变化及应对气候变化的措施；（19）信息技术基础设施的安全漏洞和其他干扰；（20）Solventum 未能获得、维护、保护或有效执行其知识产权（“IP”）权利；（21）养老金和退休后义务负债；（22）3M 公司（“3M”）未能履行与与 3M 分离相关的各种分离协议下的任何义务（“分拆”）；（23）未能实现分拆的预期利益，和/或分拆未能在预期的时间框架、预期的条款或根本未能完成；（24）美国国税局或其他税务机关认定分配或某些相关交易应视为应税交易；（25）与分拆相关的预期融资交易及与额外债务相关的风险；（26）在独立运营基础上运营的增量成本（包括协同效应的损失）、重组交易的成本及与分拆相关的其他成本超过 Solventum 的估计的风险；以及（27）分拆对其业务的影响以及分拆可能比预期更困难、耗时或成本更高的风险，包括对其资源、系统、程序和控制的影响、管理层注意力的分散以及对客户、供应商、员工和其他商业交易对手关系的影响。</p>
</div><p>Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located under &#34;Cautionary Note Regarding Forward-Looking Statements&#34; and &#34;Risk Factors&#34; in Solventum's periodic reports on file with the U.S. Securities &amp; Exchange Commission. Solventum assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.</p>
<div class="lb-trans"><p>对这些假设或因素的变化可能会产生显著不同的结果。有关这些因素的进一步描述，请参阅 Solventum 在美国证券交易委员会备案的定期报告中的 “关于前瞻性声明的警示说明” 和 “风险因素”。Solventum 不承担因新信息或未来事件或发展而更新本文中讨论的任何前瞻性声明的义务。</p>
</div><p>*Compared to waste generated by 3M Bowie-Dick paper test packs. Waste mass based on eBowie-Dick 10135B product and packaging case weight, with percent calculated on per test basis.</p>
<div class="lb-trans"><p>* 与 3M Bowie-Dick 纸质测试包产生的废物相比。废物质量基于 eBowie-Dick 10135B 产品和包装箱重量，按每个测试计算百分比。</p>
</div><p>**Some countries may be delayed due to additional local regulatory requirements</p>
<div class="lb-trans"><p>** 某些国家可能因额外的地方监管要求而延迟。</p>
</div><p>SOURCE Solventum</p>
<div class="lb-trans"><p>来源：Solventum</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzEyJk5ld3NJdGVtSWQ9Q0czODk2OSZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMTIwODEyUFJfTkVXU19VU1BSX19fX19DRzM4OTY5" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG38969&amp;Transmission_Id=202503120812PR_NEWS_USPR_____CG38969&amp;DateId=20250312"/></p>

08:12 ET Solventum 推出 Attest™ eBowie-Dick 测试系统，革新灭菌保障